Clinical Trial Update: Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis

View source ↗

Summary

Update on an individual patient expanded access IND using autologous HBadMSCs to treat amyotrophic lateral sclerosis. The status shows the trial is no longer av…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• HBadMSCs

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Amyotrophic Lateral Sclerosis | Status: NO_LONGER_AVAILABLE